Partek Flow 4.0 is now shipping and delivers new analyses, visualizations, and features that reveal the biological meaning of your RNA-Seq data quicker and easier than ever before. We’re pretty excited about these features and think you will be too. Take a peek.
Blog - In the News
News of Note: Partek® Flow® 4.0 for NGS Analysis Now ShippingJanuary 20, 2015
Recent Publications: Selected ListJanuary 20, 2015
Researchers around the world are using Partek software to make biological discoveries. To date, approximately 3,000 peer-reviewed articles using Partek software have been published.
RNA-Seq Analysis Pipeline for Ion Torrent™ DataJanuary 20, 2015
Do you have RNA sequencing data from an Ion Torrent machine? Then download the Whole Transcriptome analysis pipeline for Ion Torrent and load it into your Partek Flow instance. We partnered with Ion Torrent to pinpoint the ideal analysis settings and have stored them in this pipeline to make your analysis process simple and painless.
Partek® Genomics Suite® Now Supports 64-bit Mac OS X MavericksJanuary 20, 2015
We’re pleased to announce that Partek Genomics Suite now supports operating systems that use 64-bit functionality such as Mac OS X Mavericks and Yosemite. This added support will allow better speed and functionality for large-scale studies as well as offer the native look and feel of the operating system on which it runs.
Researchers at Queen’s University of Belfast Use Partek Software in First Steps Toward Therapies for Chronic Kidney DiseaseJanuary 18, 2015
Large, genome-wide quantitative evaluation of DNA methylation associated with chronic kidney disease (CKD) reveals several genes with strong biological evidence for differential methylation. RNA-Seq analysis was performed using Partek® Flow® and Partek® Genomics Suite® to confirm the functional role of differential methylation in ELMO1 and PRKAG2. Findings were validated by functional enrichment using Partek® Pathway™. These results could be the first step toward identifying epigenetic therapies for CKD.
Using Partek Software in Leukemia ResearchFebruary 3, 2014
A study by Alexander Thompson, PhD of the Centre for Cancer Research and Cell Biology, Queen’s University of differential gene expression in cytogenetically normal subtype of acute myeloid leukemia cells reveals a HOX/TALE signature that may have specific prognostic value. Direct gene targeting of HOXA/PBX3 sensitizes these cells to standard chemotherapy, laying a foundation for a novel therapeutic strategy.
Recent Publications: Selected ListFebruary 3, 2014
Researchers around the world are using Partek software to make biological discoveries. Over 860 new peer reviewed articles using Partek software were published in 2013 for a total of more than 3,000 publications.
Tech Tip: Recommended Aligners by ApplicationFebruary 3, 2014
If you've ever wondered what aligner to use for your application, then download this handy guide compiled by our technical experts. Download now.
Updates in Partek SoftwareFebruary 3, 2014
Partek software supports all microarray, next generation sequencing, and qPCR platforms. Regardless of which data you are analyzing, our software will take your study from start to finish. Here are some of the latest additions to our software tools.
Recent Webinar RecordingsFebruary 3, 2014
Take a look at these recordings to see how Partek software can help in your research.